Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease
- 1 January 2021
- journal article
- research article
- Published by Elsevier BV in Respiratory Investigation
- Vol. 59 (1), 90-98
- https://doi.org/10.1016/j.resinv.2020.08.002
Abstract
No abstract availableOther Versions
Funding Information
- JSPS KAKENHI (16K09576)
This publication has 36 references indexed in Scilit:
- The natural history of progressive fibrosing interstitial lung diseasesRespiratory Research, 2019
- Lack of whey acidic protein four disulphide core (WFDC) 2 protease inhibitor causes neonatal death from respiratory failure in miceDisease Models & Mechanisms, 2019
- Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseasesEuropean Respiratory Review, 2018
- Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosisNature Medicine, 2013
- Classification and Natural History of the Idiopathic Interstitial PneumoniasProceedings of the American Thoracic Society, 2006
- WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lungRespiratory Research, 2006
- Comprehensive analysis of HE4 expression in normal and malignant human tissuesLaboratory Investigation, 2006
- The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoformsOncogene, 2002
- Molecular characterization of epididymal proteinsReviews of Reproduction, 1998
- A Major Human Epididymis-Specific cDNA Encodes a Protein with Sequence Homology to Extracellular Proteinase Inhibitors1Biology of Reproduction, 1991